ID16434A - Senyawa-senyawa 1,4-dihidropiridin - Google Patents

Senyawa-senyawa 1,4-dihidropiridin

Info

Publication number
ID16434A
ID16434A IDP970467A ID970467A ID16434A ID 16434 A ID16434 A ID 16434A ID P970467 A IDP970467 A ID P970467A ID 970467 A ID970467 A ID 970467A ID 16434 A ID16434 A ID 16434A
Authority
ID
Indonesia
Prior art keywords
dihydropiridins
compounds
Prior art date
Application number
IDP970467A
Other languages
English (en)
Indonesian (id)
Inventor
Takafumi Ikeda
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ID16434A publication Critical patent/ID16434A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
IDP970467A 1996-02-19 1997-02-18 Senyawa-senyawa 1,4-dihidropiridin ID16434A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9600132 1996-02-19
PCT/IB1997/000058 WO1997030048A1 (fr) 1996-02-19 1997-01-27 Composes de 1,4-dihydropyridine utilises comme antagonistes de la bradykinine

Publications (1)

Publication Number Publication Date
ID16434A true ID16434A (id) 1997-09-25

Family

ID=11004406

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970467A ID16434A (id) 1996-02-19 1997-02-18 Senyawa-senyawa 1,4-dihidropiridin

Country Status (34)

Country Link
US (1) US6131226A (fr)
EP (1) EP0882044B1 (fr)
JP (1) JP3167335B2 (fr)
KR (1) KR19990082678A (fr)
CN (1) CN1211251A (fr)
AR (1) AR005841A1 (fr)
AT (1) ATE220676T1 (fr)
AU (1) AU1396497A (fr)
BG (1) BG102678A (fr)
BR (1) BR9707568A (fr)
CA (1) CA2245857C (fr)
CO (1) CO4650041A1 (fr)
CZ (1) CZ258698A3 (fr)
DE (1) DE69714019T2 (fr)
DK (1) DK0882044T3 (fr)
ES (1) ES2177921T3 (fr)
HN (1) HN1997000013A (fr)
HR (1) HRP970094A2 (fr)
HU (1) HUP9902810A3 (fr)
ID (1) ID16434A (fr)
IL (1) IL124867A0 (fr)
IS (1) IS4783A (fr)
MA (1) MA26419A1 (fr)
NO (1) NO983776D0 (fr)
NZ (1) NZ325455A (fr)
OA (1) OA10712A (fr)
PE (1) PE36298A1 (fr)
PL (1) PL328514A1 (fr)
PT (1) PT882044E (fr)
SI (1) SI0882044T1 (fr)
TN (1) TNSN97037A1 (fr)
TR (1) TR199801593T2 (fr)
WO (1) WO1997030048A1 (fr)
ZA (1) ZA971357B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
GB0427281D0 (en) * 2004-12-14 2005-01-12 3M Innovative Properties Co Methods of providing medicinal metal components having through holes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120750A (en) * 1989-01-17 1992-06-09 Synphar Laboratories, Inc. Generation of 1,4-dihydropyridine derivatives
WO1996006083A1 (fr) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines utilisees comme antagonistes de bradykinine
MX9701245A (es) * 1996-02-19 1998-04-30 Pfizer Compuestos de 1,4 dihidropiridina.

Also Published As

Publication number Publication date
JPH11507949A (ja) 1999-07-13
JP3167335B2 (ja) 2001-05-21
BG102678A (en) 1999-04-30
SI0882044T1 (en) 2002-10-31
DE69714019T2 (de) 2002-11-14
PT882044E (pt) 2002-11-29
EP0882044B1 (fr) 2002-07-17
HUP9902810A2 (hu) 2000-05-28
CA2245857A1 (fr) 1997-08-21
OA10712A (en) 2001-06-04
NO983776L (no) 1998-08-18
HRP970094A2 (en) 1998-06-30
ZA971357B (en) 1998-08-18
AR005841A1 (es) 1999-07-14
AU1396497A (en) 1997-09-02
HN1997000013A (es) 1997-06-26
TNSN97037A1 (fr) 2005-03-15
CA2245857C (fr) 2002-10-01
NO983776D0 (no) 1998-08-18
PE36298A1 (es) 1998-07-18
CZ258698A3 (cs) 1999-06-16
MA26419A1 (fr) 2004-12-20
BR9707568A (pt) 1999-07-27
KR19990082678A (ko) 1999-11-25
DE69714019D1 (de) 2002-08-22
HUP9902810A3 (en) 2000-09-28
IL124867A0 (en) 1999-01-26
ES2177921T3 (es) 2002-12-16
US6131226A (en) 2000-10-17
CO4650041A1 (es) 1998-09-03
NZ325455A (en) 1999-07-29
PL328514A1 (en) 1999-02-01
EP0882044A1 (fr) 1998-12-09
ATE220676T1 (de) 2002-08-15
WO1997030048A1 (fr) 1997-08-21
DK0882044T3 (da) 2002-09-02
CN1211251A (zh) 1999-03-17
IS4783A (is) 1998-06-25
TR199801593T2 (xx) 1999-12-21

Similar Documents

Publication Publication Date Title
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID15904A (id) Senyawa-senyawa tiofenopirimidina
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
BR9710352A (pt) Compostos piridilpirrole
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
ID18685A (id) Senyawa trisiklik tersubstitusi
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
EE9800430A (et) Uued ühendid
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
BR9705635A (pt) Compostos
DK0923594T3 (da) Bromotiacumicinforbindelser
NO992059D0 (no) 2-metoksyfenylpiperazinderivater
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
BR9706702A (pt) Purificação de 1,1,1,3,3-pentafluorpropano
BR9709521A (pt) &#34;3-Cianoaril-pirazóis&#34;
EE9900012A (et) Uudsed ühendid
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
SE9601599D0 (sv) Novel compounds
SE9601787D0 (sv) New compounds